Global Bioinformatics Market

Global Bioinformatics Market Size, Share, Growth Analysis, By Products And Services(Knowledge Management Tools, Bioinformatics Platform (Sequence Analysis Platform), By Application(Microbial Genome, Gene Engineering) - Industry Forecast 2024-2031


Report ID: SQMIG35H2059 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 75 | Figures: 75

Global Bioinformatics Market News

  • In May 2022, BioSkryb Genomics in collaboration with its innovative bioinformatics platform, BaseJumper launched ResolveOME Early Access Program for full genome and transcriptome amplification from a single cell.
  • In July 2021, Indivumed GmbH has launched nRavel, a one-of-a-kind AI discovery platform for oncology and precision medicine. IndivuType's deep multi-omics data is combined with elaborate disease models, high-powered automated Machine Learning tools, and a comprehensive suite of advanced analytics tools on the platform.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Bioinformatics Market size was valued at USD 13.2 billion in 2019 and is poised to grow from USD 15.35 billion in 2023 to USD 45.6 billion by 2031, growing at a CAGR of 16.3% in the forecast period (2024-2031).

The key players have a strong foothold in the Bioinformatics Market and offer a wide range of products & services. Some of the key players in this Bioinformatics Market are Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Agilent Technologies, Inc., and Illumina, Inc. among others. 'Illumina Inc.', 'Thermo Fisher Scientific Inc.', 'Qiagen N.V.', 'Agilent Technologies Inc.', 'BGI Group', 'PerkinElmer Inc.', 'Eurofins Scientific SE', 'Waters Corporation', 'DNAnexus Inc.', 'Sophia Genetics SA', 'Partek Incorporated', 'Gene Codes Corporation', 'Dassault Systemes SE', 'Biomax Informatics AG', 'Bruker Corporation', 'GenoLogics Life Sciences Software Inc.', 'Nonlinear Dynamics Ltd. (Waters Corporation)', 'Genedata AG', 'Knome Inc.', 'Macrogen Inc.'

Increasing demand for protein sequencing and nucleic acid along with initiatives from government and private organizations is bolstering the demand for bioinformatics in the global market. The market is further driven by increased research on drug delivery and molecular biology accompanied by growth in genomics and proteomics. Demand for computational epigenetics, a meta-analysis of microarray data, differentially expressed genes, gene networks, systems biology requirements, and gene-associating studies, among other things, have had a significant impact on the growth of the bioinformatics market. 

Advances in Pharmacogenics to create market opportunities: Advances in systems biology and pharmacogenomics have helped personalized medicine in transitioning from disease-centered and reductionist medicine to system-based, integrative, and human-centered care. 

North America dominated the Bioinformatics Market in 2022, accounting for the majority of the bioinformatics market share, and this trend is expected to continue throughout the forecast period. This is due to an increased demand for improved bioinformatics tools, which are required for drug research and development, as well as an increase in the use of sophisticated technologies. The bioinformatics market in Asia-Pacific is expected to grow at the fastest CAGR during the forecast period. Furthermore, the region's bioinformatics industry is still in its infancy, with gradual research activities ongoing.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bioinformatics Market

Product ID: SQMIG35H2059

$5,300
BUY NOW GET FREE SAMPLE